Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > Return on Equity %

Acadia Pharmaceutica Return on Equity % Chart (ACAD)

Acadia Pharmaceutica annual/quarterly Return on Equity % from 2010 to 2020.
  • Acadia Pharmaceutica Return on Equity % for the quarter ending June 06, 2020 was -25.90 a -20.23% increase of 5.24 year over year
  • Acadia Pharmaceutica Return on Equity % for the last 12 months ending June 06, 2020 was -42.81 a -26.79% increase of 11.47 year over year
  • Acadia Pharmaceutica Annual Return on Equity % for 2019 was -39.93 a -50.79% increase of 20.28 from 2018
  • Acadia Pharmaceutica Annual Return on Equity % for 2018 was -60.22 a -12.59% increase of 7.58 from 2017
  • Acadia Pharmaceutica Annual Return on Equity % for 2017 was -67.80 a -11.47% increase of 7.78 from 2016
Other Margins & Efficiency Metrics:
  • Acadia Pharmaceutica EBITDA Margin for the quarter ending December 12, 2018 was $-112m a 0.94% decrease of -1m year over year
  • Acadia Pharmaceutica Return on Capital % for the quarter ending September 09, 2018 was -62.76 a 23.01% decrease of -14.44 year over year
View Chart On Koyfin

Quarterly ACAD Return on Equity % Data

06/2020-25.90
03/2020-52.65
12/2019-30.56
09/2019-31.15
06/2019-54.45
03/2019-76.04
12/2018-74.58
09/2018-101.83
06/2018-88.97
03/2018-67.93

Annual ACAD Return on Equity % Data

2019-39.93
2018-60.22
2017-67.80
2016-75.58
2015-64.58
2014-37.62
2013-28.41
2012-38.49
2011-85.82
201072.43